Abstract
Overuse of short-acting β2-agonist (SABA) inhalers to manage asthma is associated with increased risk of adverse outcomes. Over-the-counter (OTC) SABA availability and automated practitioner provision of up to 12 inhalers/prescription has created the perfect storm for potential SABA overuse in Australia.
Original language | English |
---|---|
Article number | AO01-3 |
Pages (from-to) | 3-413 |
Number of pages | 1 |
Journal | Respirology |
Volume | 28 |
Issue number | S1 |
Early online date | 26 Feb 2023 |
DOIs | |
Publication status | Published - 26 Feb 2023 |
Event | APSR 2022: The 26th Congress of the Asian Pacific Society of Respirology - Coex, Seoul, Korea, Republic of Duration: 17 Nov 2022 → 20 Nov 2022 Conference number: 26 https://apsr2022.org/ http://www.apsr2022.org/ |
Bibliographical note
AcknowledgementsWe would like to acknowledge and thank Steph James, Kiran Dhillon, Sophie Jones, Rob Campbell, Ying Liu, Marion Magee, Ondrej Rejda, Lisa Sugg, and Nicole O'Sullivan for their valuable contributions.